Kausik Kumar Ray, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Regeneron(MODEST), Astra Zeneca(SIGNIFICANT), Boehringer Ingelheim(SIGNIFICANT), Esperion(MODEST), Kowa(MODEST), Amgen(SIGNIFICANT), Sanofi(SIGNIFICANT), Pfizer(MODEST), Resverlogix(SIGNIFICANT), Novo Nordisk(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Daiichi Sankyo(SIGNIFICANT), New Amsterdam Pharma(MODEST), Cargene(SIGNIFICANT), Eli Lilly and Company(MODEST), Bayer Healthcare Pharmaceuticals(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Regeneron(SIGNIFICANT), Amgen(SIGNIFICANT), Daiichi Sankyo(SIGNIFICANT), Sanofi(SIGNIFICANT)

View Full Disclosure